INNOVATE BIOPHARMACEUTICALS, INC - 48 Year Dividend Yield History | INNT

Historical dividend payout and yield for INNOVATE BIOPHARMACEUTICALS, INC (INNT) since 1971. The current TTM dividend payout for INNOVATE BIOPHARMACEUTICALS, INC (INNT) as of March 25, 2019 is $0.00. The current dividend yield for INNOVATE BIOPHARMACEUTICALS, INC as of March 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.053B $0.004B
Innovate Biopharmaceuticals, Inc. is a clinical stage biotechnology company. It focused on developing novel medicines for autoimmune/ inflammatory disease. The company's pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Its products includes INN-202 for the treatment of Celiac Disease with fast track designation, INN-108 for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis and a GI orphan disease in a convenient liquid formulation, INN-329 for Magnetic Resonance Cholangiopancreatography which are in clinical stages. Innovate Biopharmaceuticals Inc., formerly known as Monster Digital, Inc., is based in SIMI VALLEY, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.179B 12.96
Gilead Sciences (GILD) United States $81.339B 10.35
Bio-Techne Corp (TECH) United States $7.264B 48.94